Suppr超能文献

甲状腺乳头状癌的家族史是否表明患有这种肿瘤的患者应接受更积极的治疗?

Should a family history of papillary thyroid carcinoma indicate more aggressive therapy in patients with this tumor?

作者信息

Rosario Pedro Weslley, Calsolari Maria Regina

机构信息

Santa Casa de Belo Horizonte, MG, Brazil.

Endocrinology Service, Santa Casa de Belo Horizonte, MG, Brazil.

出版信息

Arq Bras Endocrinol Metabol. 2014 Nov;58(8):812-6. doi: 10.1590/0004-2730000003350. Epub 2014 Nov 1.

Abstract

OBJECTIVE

To determine whether the currently recommended therapy for papillary thyroid carcinoma (PTC) that show no classical factors indicating a poor prognosis is also effective in cases with a family history of this tumor.

SUBJECTS AND METHODS

Forty-two patients were studied; 10 were submitted to lobectomy and 32 to total thyroidectomy, including 23 without lymph node dissection and 9 with lymph node dissection. None of the patients received radioiodine or was maintained under TSH suppression.

RESULTS

No case of recurrence was detected by imaging methods and there was no increase in thyroglobulin or antithyroglobulin antibodies during follow-up (24 to 72 months).

CONCLUSION

The treatment usually recommended for patients with PTC does not need to be modified in the presence of a family history of this tumor if no factors indicating a poor prognosis are present (tumor ≤2 cm, non-aggressive histology, no extensive extrathyroid invasion or important lymph node involvement, complete tumor resection, no evidence of persistent disease after surgery).

摘要

目的

确定目前推荐用于无提示预后不良经典因素的乳头状甲状腺癌(PTC)的治疗方法,对于有该肿瘤家族史的病例是否也有效。

对象与方法

研究了42例患者;10例行叶切除术,32例行全甲状腺切除术,其中23例未行淋巴结清扫,9例行淋巴结清扫。所有患者均未接受放射性碘治疗,也未在促甲状腺激素(TSH)抑制状态下维持治疗。

结果

通过影像学方法未检测到复发病例,随访期间(24至72个月)甲状腺球蛋白或抗甲状腺球蛋白抗体也未升高。

结论

如果不存在提示预后不良的因素(肿瘤≤2 cm、组织学无侵袭性、无广泛甲状腺外侵犯或重要淋巴结受累、肿瘤完全切除、术后无持续性疾病证据),对于有PTC家族史的患者,通常推荐的治疗方法无需改变。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验